je.st
news
Merck to Participate at the Morgan Stanley Global Healthcare Conference
2014-09-08 23:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer; Adam H. Schechter, executive vice president and president, Global Human Health; and Dr. Roy Baynes, senior vice president, Clinical Development, Merck Research Laboratories, are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York on Sept. 9, 2014 at 8:00 a.m. EDT. Language: English Contact: MerckMedia:Lainie Keller, 308-423-4187orInvestors:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: global
conference
participate
morgan
Category:Biotechnology and Pharmaceuticals